UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

The American heart journal, 2019-08, Vol.214, p.60-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers

Annals of the rheumatic diseases, 2018-02, Vol.77 (2), p.281

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.684

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

Journal of the American College of Cardiology, 2005-03, Vol.45 (5), p.712-719

2005

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death the life study

Circulation (New York, N.Y.), 2007-08, Vol.116 (7), p.700-705

2007

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

JAMA : the journal of the American Medical Association, 2006-09, Vol.296 (10), p.1242

2006

Link zum Volltext

Verfügbarkeit prüfen

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

The Lancet (British edition), 2021-09, Vol.398 (10305), p.1053-1064

2021

Link zum Volltext

Verfügbarkeit prüfen

Is pain associated with premature mortality in patients with psoriatic arthritis? A nested case-control study using the DANBIO Register

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5216-5223

2021

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy

Journal of hypertension, 2015-12, Vol.33 (12), p.2422-2430

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2002-09, Vol.20 (9), p.1879-1886

2002

Link zum Volltext

Verfügbarkeit prüfen

Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction

Shock (Augusta, Ga.), 2019-03, Vol.51 (3), p.321-327

2019

Link zum Volltext

Verfügbarkeit prüfen

Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study

Journal of hypertension, 2006-04, Vol.24 (4), p.775-781

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation : The losartan intervention for end point reduction in hypertension (LIFE) study

Journal of the American College of Cardiology, 2005-03, Vol.45 (5), p.705-711

2005

Link zum Volltext

Verfügbarkeit prüfen

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Annals of internal medicine, 2003-12, Vol.139 (11), p.901

2003

Link zum Volltext

Verfügbarkeit prüfen

Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMI

International journal of cardiology, 2017-12, Vol.249, p.55-60

2017

Link zum Volltext

Verfügbarkeit prüfen

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

Journal of hypertension, 2004-09, Vol.22 (9), p.1805-1811

2004

Link zum Volltext

Verfügbarkeit prüfen

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52

2005

Link zum Volltext

Verfügbarkeit prüfen

Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study

American journal of hypertension, 2010-08, Vol.23 (8), p.845-851

2010

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study

Circulation. Arrhythmia and electrophysiology, 2008-12, Vol.1 (5), p.337-343

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2009-03, Vol.27 (3), p.567-574

2009

Link zum Volltext

Verfügbarkeit prüfen

Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

Journal of hypertension, 2012-06, Vol.30 (6), p.1252-1259

2012

Link zum Volltext

Verfügbarkeit prüfen

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy : The LIFE (losartan intervention for endpoint reduction in hypertension) study

Circulation (New York, N.Y.), 2005-04, Vol.111 (15), p.1924-1931

2005

Link zum Volltext

Verfügbarkeit prüfen

Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study

American journal of hypertension, 2008-03, Vol.21 (3), p.273-279

2008

Link zum Volltext

Verfügbarkeit prüfen

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension : the RENAAL and LIFE studies

Journal of hypertension, 2007-04, Vol.25 (4), p.871-876

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Aged
(26)
Humans
(26)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Female
(25)
Male
(25)
Cardiovascular System & Cardiology
(20)
Antihypertensive Agents - Therapeutic Use
(15)
Hypertension - Drug Therapy
(15)
Losartan - Therapeutic Use
(15)
Risk Factors
(15)
Atenolol - Therapeutic Use
(14)
Peripheral Vascular Disease
(14)
Aged, 80 And Over
(13)
Hypertension
(13)
Medicin Och Hälsovetenskap
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Cardiology. Vascular System
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers

Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death the life study

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Is pain associated with premature mortality in patients with psoriatic arthritis? A nested case-control study using the DANBIO Register

Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction

Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation : The losartan intervention for end point reduction in hypertension (LIFE) study

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMI

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study

Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy : The LIFE (losartan intervention for endpoint reduction in hypertension) study

Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension : the RENAAL and LIFE studies

Aktive Filter

Suchergebnisse filtern